These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer. Yamada K; Saijo N; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Goya T; Kondou H Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633 [TBL] [Abstract][Full Text] [Related]
24. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation. Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775 [TBL] [Abstract][Full Text] [Related]
25. Sequential combined modality therapy for stage III non-small cell lung cancer. Vokes EE Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Zheng Y; Jaklitsch MT; Bueno R Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916 [TBL] [Abstract][Full Text] [Related]
27. Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it? Perry MC J Clin Oncol; 2006 Aug; 24(24):3815-6. PubMed ID: 16921030 [No Abstract] [Full Text] [Related]
28. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722 [TBL] [Abstract][Full Text] [Related]
29. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study. Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818 [TBL] [Abstract][Full Text] [Related]
30. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
31. Current standards of care in small-cell and non-small-cell lung cancer. Schiller JH Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409 [TBL] [Abstract][Full Text] [Related]
32. [Concomitant radiochemotherapy for locally advanced bronchial cancers: current results and prospects]. Reboul F; Vincent P; Brewer Y; Taulelle M Cancer Radiother; 1997; 1(2):113-20. PubMed ID: 9273180 [TBL] [Abstract][Full Text] [Related]
33. Combined modality treatment of non-small-cell lung cancer. Westeel V; Depierre A Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987 [TBL] [Abstract][Full Text] [Related]
34. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Bunn PA Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874 [TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. Johnson DH; Bass D; Einhorn LH; Crawford J; Perez CA; Bartolucci A; Omura GA; Greco FA J Clin Oncol; 1993 Jul; 11(7):1223-9. PubMed ID: 8391064 [TBL] [Abstract][Full Text] [Related]
36. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial. Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment? Bunn PA; Mault J; Kelly K Chest; 2000 Apr; 117(4 Suppl 1):119S-122S. PubMed ID: 10777465 [TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893 [TBL] [Abstract][Full Text] [Related]
39. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194 [TBL] [Abstract][Full Text] [Related]
40. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]